Millennium Management Acquires 5.1% Passive Stake in Tenax Therapeutics, Inc.

On May 18, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G indicating they have acquired a significant stake in Tenax Therapeutics, Inc. (TENX). The filers reported beneficial ownership of 1,347,130 shares of Common Stock, representing 5.1% of the company's outstanding shares. This filing marks a new passive position for the investment firm, as the previous ownership was reported at 0.0%. The shares are held by various entities subject to the voting and investment control of Millennium Management LLC, overseen by Millennium Group Management LLC and its sole voting trustee, Israel A. Englander. The filing was made under Rule 13d-1(c), certifying that the shares were not acquired for the purpose of changing or influencing the control of the issuer. The principal executive offices of Tenax Therapeutics are located in Chapel Hill, North Carolina.